August 11, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG-CC015 Study Webinar

August 19, 2025

The NRG-CC015 study team will be hosting a webinar on August 19, 2025, 1–2 pm ET to provide an overview of the trial, Harnessing E-Mindfulness Approaches for Living-After Breast Cancer (HEAL-ABC).

Please register in advance

CLOSURE

HEAD & NECK

NRG-HN010: HER2-Low Expressing Cohort Temporary Closure, dated August 11, 2025 (posted on CTSU)

FORM UPDATES

CANCER CARE DELIVERY RESEARCH

NRG-CC012CD: A revised Spanish Bayliss tool and CIRB approval is posted on CTSU. 

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANK

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BREAST

NRG-BR009/OFSET: Site-Directed Video Tools

4. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: FORTE Fridays eNewsletter

5. GASTROINTESTINAL

NRG-GI008: Memorandum, dated August 8, 2025, with important reminders regarding baseline tumor submissions (posted on CTSU)

6. GENITOURINARY

NRG-GU011: Updated Temperature Excursion Form, posted on CTSU.

7. GYNECOLOGIC

NRG-GY025: Study is currently on a brief accrual hold while safety is evaluated on the first 25 patients randomized to Arm 1, per the safety lead-in plan. You will be notified when accrual can resume.

NRG-GY026: Reminder! Now accruing patients of all stages and all histologic subtypes of endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

8. HEAD & NECK

NRG-HN008: Reminder! Please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

9. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-BN014, NRG-BR009, NRG-CC003, NRG-CC005, NRG-CC011, NRG-CC013, NRG-CC014, NRG-CC015, and NRG-HN014. Space is limited so register now and reserve your seat. The next webinar training is scheduled for August 13, 2025.

Investigator Brochure (IB) updates have been issued for the following studies:

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Agent Inventory Management System (AURORA) application. Log-in using your Identity and Access Management (IAM) or ID.me credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

1. NRG Health Care Access Fellowship – Call for Applications

NRG Oncology is currently seeking applications for the NRG Care Access Fellowship. This program trains selected early-stage investigators in the NRG Oncology system by means of a structured mentorship experience, with particular emphasis given to the recruitment of researchers with a passion for improving health care access. Our vision is to have at least one scholar for every disease site we study. The deadline for applications is September 19, 2025, and awards will be announced in November. Fellowship Start Date: January 1, 2026.

Applications DUE September 19, 2025 - Read more and how to apply

2. RFA for Medical Oncologist Vice Chair, NRG Oncology Head and Neck Cancer Committee

Applications DUE September 1, 2025 - Read more and how to apply

3. RFA for Medical Oncologist Vice Chair, NRG Oncology Lung Cancer Committee

Applications DUE September 1, 2025 - Read more and how to apply



5. PSC launches “Discuss With Us” monthly series

The NRG Oncology Protocol Support Committee (PSC) is excited to announce the inaugural launch of Discuss With Us session on Wednesday, August 20, 2025 at 2 pm ET.

PSC Discuss With Us is an interactive forum for research staff to engage with one another, to ignite conversation and exchange information, with the goal that we continue to evolve as researchers and caregivers.

Each session will focus on a relevant research topic and will include a brief presentation from PSC members, as well as a subject matter expert. This is an excellent opportunity for research professionals from different backgrounds to learn about a new topic, or to share their expertise in an area that is known to them. All are welcome to attend and join in on the conversation. View the flyer for details about the August session.

PSC Discuss With Us will take place via zoom on the 3^rd Wednesday of every month at 2pm ET (1pm CT/12pm MT/11am PT) for 1 hour. Once you register you will be given a calendar invite for all future sessions. Use this link or the QR code below to register today!

Additional information including future topics can be found in the NRG Oncology eNewsletter and on NRG social media accounts. We look forward to having you in the conversation!

6. NRG Oncology Meeting

NRG Oncology would like to thank our attendees for joining us in Washington, DC for an eventful and engaging NRG Meeting! We would also like to thank those who joined us virtually for our online sessions. Please check the NRG Oncology Meeting Webpages in the coming days for session presentation slide postings as they become available.

We hope that you join us for our Winter Meeting, NRG2026 in San Francisco - January 22-24, 2026.

7. NRG Member Information Form

We are excited to introduce the NRG Member Information Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

Any manuscript or abstract resulting from research conducted under the auspices of our NCI grant awards must be processed through the NRG Publications Office before being submitted to the journal or association.

Please reach out to NRG-Publications@NRGOncology.org as a first step to ensure all requirements are met.

PUBLISHED ARTICLES

Hamstra DA, Dignam JJ, Bruner DW, Michaelson MD, Bachand F, Master V, Torres MA, Saylor PJ, Wallace RE, Vapiwala N, Efstathiou JA, Roach M 3rd, Rosenthal SA, Raben A, Morgan SC, Kavadi VS, Spratt DE, Michalski JM, Seiferheld W, Pugh SL, Movsas B, Sandler H. Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) vs. dose escalated radiation therapy and enhanced ADT with orteronel for men with high-risk prostate cancer (NRG/RTOG 1115). Int J Radiat Oncol Biol Phys. 2025 Jul 23:S0360-3016(25)06022-5. doi: 10.1016/j.ijrobp.2025.07.1425. Epub ahead of print. PMID: 40712984. Read more

Langer CJ, Harris J, Horwitz EM, Kies M, Ad VB, Wong SJ, Caudell JJ, Zeitzer KL, Spencer SA, Zhang Q, Yom SS, Le QT. Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination with Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): Long-term follow-up of NRG Oncology Radiation Therapy Oncology Group (RTOG) Protocol 9911. Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06032-8. doi: 10.1016/j.ijrobp.2025.07.1434. Epub ahead of print. PMID: 40752652. Read more

Lukka HR, Pugh SL, Shipley WU, Major PP, Sartor O, Dayes IS, Bahary JP, Efstathiou JA, Pisansky TM, Zeitzer KL, Lawton CAF, Dess RT, Camarata AS, Balogh AG, Souhami L, Rosenthal SA, Pennington JD, Seiferheld WF, Feng FY, Sandler HM. Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy. Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06014-6. doi: 10.1016/j.ijrobp.2025.07.1416. Epub ahead of print. PMID: 40752653. Read more

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS:

AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Sep 18-21, 2025; Baltimore, MD

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB

PA Breast Cancer Coalition (PBCC); Oct 15, 2025; Harrisburg, PA

International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI

Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL

Society for Immunotherapy of Cancer (SITC); Nov 5-9, 2025; National Harbor, MD

UPCOMING ABSTRACT SUBMISSION DEADLINES:

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; Oct 22-26, 2025; Boston, MA; LBA and Clinical Trials Sep 10, 2025, 1:00 pm ET

American Society of Clinical Oncology (ASCO) GI; Jan 8-10, 2026; San Francisco, CA; Due to publications committee Aug 26, 2025; Submission deadline Sep 9, 2025, 11:59 pm ET; LBA Oct 9, 2025, 12:00 pm ET

American Society of Colon and Rectal Surgeons (ASCRS); May 9-12, 2026; Tampa, FL; Due to publications committee Sep 30, 2025; Submission deadline Oct 14, 2025, 11:59 pm ET; LBA / Clinical Trials Jan 28, 2026

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; LBA Sep 9, 2025, 21:00 CET (placeholder required)

European Society of Gynaecological Oncology (ESGO); Feb 26-Mar 1, 2026; Copenhagen, Denmark; Due to publications committee Oct 17, 2025; Submission deadline Oct 31, 2025, 23:59 CET; LBA Jan 15, 2026

European Society for Radiotherapy and Oncology (ESTRO); May 15-19, 2026; Stockholm, Sweden; Due to publications committee Oct 29, 2025; Submission deadline Nov 12, 2025; LBA Apr 8, 2026

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2025; Cape Town, South Africa; LBA Sep 29, 2025 (placeholder required)

San Antonio Breast Cancer Symposium (SABCS); Dec 9-12, 2025; San Antonio, TX; LBA Sep 30, 2025, 11:59 pm CT

Society for Neuro-Oncology (SNO); Nov 19-23, 2025; Honolulu, HI; LBA Sep 2, 2025, 5:00 pm ET

SSO - Advanced Cancer Therapies; Feb 14-16, 2026; Fort Lauderdale, FL; Due to publications committee Oct 6, 2025; Submission deadline Oct 20, 2025



Society of Urologic Oncology (SUO); Dec 2-5, 2025; Dallas, TX; Submission deadline Aug 5, 2025; LBA Oct 1, 2025